The management of children with lymphomas

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Hematology

Background:

• Lymphomas represent 10-15% of childhood cancers, with high survival rates for both Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
• Historically, radiotherapy was a cornerstone in treating pediatric lymphomas, but concerns over late toxicities like secondary malignancies led to its reduced use.
• Current NHL treatment is primarily chemotherapy-based, largely eliminating radiotherapy, while pediatric HL protocols still incorporate it judiciously.

Purpose of the Study:

• To review the current treatment strategies for pediatric Hodgkin lymphoma.
• To emphasize the evolving role and application of radiotherapy in managing childhood Hodgkin lymphoma.
• To discuss the balance between treatment efficacy and reducing long-term morbidity.

Main Methods:

• Review of current pediatric Hodgkin lymphoma treatment protocols.
• Analysis of the historical and current use of radiotherapy in pediatric lymphoma management.
• Discussion of risk-adapted and response-based radiotherapy application.

Main Results:

• Radiotherapy has been virtually eliminated in pediatric non-Hodgkin lymphoma treatment.
• Pediatric Hodgkin lymphoma protocols continue to utilize radiotherapy as part of combined modality treatment.
• Radiotherapy is applied at the minimum effective dose, targeted by risk factors and treatment response.

Conclusions:

• Modern pediatric Hodgkin lymphoma treatment focuses on minimizing treatment-related morbidity while preserving excellent outcomes.
• Radiotherapy remains an important component in selected pediatric Hodgkin lymphoma cases, used cautiously and precisely.
• The trend is towards optimizing radiotherapy delivery to reduce late effects in survivors of childhood Hodgkin lymphoma.